Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
Dendritic cell (DC) vaccines are a safe and effective means of inducing tumor immune responses, however, a better understanding of DC biology is required in order to realize their full potential.Recent Quilt Hangers advances in DC biology have identified a crucial role for cDC1 in tumor immune responses, making this DC subset an attractive vaccine